03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Zirabev 100mg : | |
Type | Medicine Authorised |
Originator | Biotech (Avastin 100mg) |
Agent | Droguerie Fattal |
Distributor | Droguerie Fattal |
Laboratory | Pfizer |
Responsible Party | Pfizer Inc |
Origin | U.S.A. |
Manufacturer | Pharmacia & Upjohn Company |
Origin | U.S.A. |
ATC | L01XC07 |
Zirabev 100mg :
Zirabev 100mg :
Zirabev 100mg :
Zirabev 100mg :
Zirabev 100mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Zirabev 100mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abscess | Common |
Anaemia | Common |
Aneurysm | Not known |
Anorexia | Very Common |
Artery dissection | Not known |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Asthenia | Very Common |
Back pain | Common |
Cellulitis | Common |
Cerebrovascular accident | Common |
Congestive heart failure | Common |
Constipation | Very Common |
Cough | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Dermatitis exfoliative | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dry skin | Very Common |
Dysarthria | Very Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dysphonia | Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Eye disorder | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Very Common |
Fistula | Common |
Foetal abnormalitie | Not known |
Gallbladder perforation | Not known |
Gastrointestinal disorders | Common |
Gastrointestinal perforation | Common |
Gastrointestinal ulcer | Not known |
Haemoptysis | Common |
Haemorrhage | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Headache | Very Common |
Hypersensitivity | Common |
Hypertension | Very Common |
Hypertensive encephalpathy | Very rare |
Hypomagnesaemia | Very Common |
Hyponatraemia (Hyponatremia) | Very Common |
Hypoxia | Common |
Ileus | Common |
Infection | Common |
Infusion related reaction | Common |
Intestinal obstruction | Common |
Intestinal perforation | Common |
Lacrimation increased (Epiphora) | Very Common |
Lethargy | Common |
Leucopenia (Leukopenia) | Very Common |
Lymphopenia | Common |
Mucosal inflammation | Very Common |
Muscle weakness | Common |
Myalgia | Very Common |
Nasal septum perforation | Not known |
Nausea | Very Common |
Necrotizing fasciitis | Rare |
Neutropenia | Very Common |
Non-mandibular osteonecrosis | Not known |
Osteonecrosis of the jaw | Not known |
Ovarian failure | Very Common |
Pain | Very Common |
Pelvic pain | Common |
Peripheral sensory neuropathy | Very Common |
Posterior reversible leukoencephalopathy syndrome (PRES) | Rare |
Proctalgia | Common |
Proteinuria | Very Common |
Pulmonary embolism | Common |
Pulmonary haemorrhage | Common |
Pulmonary hypertension | Not known |
Pyrexia | Very Common |
Rectal haemorrhage | Very Common |
Recto-vaginal fistulae | Common |
Renal-limited thrombotic microangiopathy | Not known |
Rhinitis | Very Common |
Sepsis (Systemic infection) (Sepsis state) | Common |
Skin discolouration (Dyschromia) | Very Common |
Somnolence | Common |
Stomatitis | Very Common |
Supraventricular tachycardia | Common |
Syncope | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Thromboembolism arterial | Common |
Thromboembolism venous | Very Common |
Urinary tract infection | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Wound healing complications | Very Common |
Zirabev 100mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Zirabev 100mg MoH 10287 :
Form | Concentrate for solution for infusion |
Packaging | Vial (Type I Glass) |
Package Size | 1x4ml |
Package Content | 4 ml solution in a vial (Type I glass) with a stopper (butyl rubber) |
Strength | 100mg |
Storage Condition | 2-8°C Do not freeze |
Public Price | 2809741.29 L.L. |
Stratum | D |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 100120/1 |
Submission date | 2020 |
Registration Year | 03/12/2020 |
Price Comparison
● Country: | Germany | |
● Package Size: | 1 | |
● Public Price: | 435.13 EUR | ( 42,153,653.88 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 435,13 EUR | ( 42,141,060.00 LBP ) |
● Pricing Date: | 24/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 1x4ml | |
● Public Price: | 2819 DKK | ( 36,579,344.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2819 DKK | ( 36,579,344.00 LBP ) |
● Pharmacy Price: | 2090.82 DKK | ( 27130480.32 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 1x4ml | |
● Public Price: | 312.1 CHF | ( 32,277,382.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 312,1 CHF | ( 32,267,040.00 LBP ) |
● Exfactory Price: | 257.57 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1x4ml | |
● Public Price: | 295 EUR | ( 28,578,420.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 295 EUR | ( 28,578,420.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 07/12/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1x4ml | |
● Public Price: | 225.67 GBP | ( 25,647,169.83 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 225,67 GBP | ( 25,571,025.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 1x4ml | |
● Public Price: | 247.99 EUR | ( 24,024,279.24 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 247,99 EUR | ( 23,928,372.00 LBP ) |
● Exfactory Price: | 199.12 EUR | |
● Pharmacy Price: | 208.88 EUR | ( 20235458.88 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 |
● Country: | KSA | |
● Package Size: | 4ml | |
● Public Price: | 780.699 SAR | ( 18,455,724.36 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 780,699 SAR | ( 18,439,200.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Concentrate for solution for infusion | |
● Package Size: | 1x4ml | |
● Public Price: | 2809741.29 LBP | ( 2,809,741.29 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2809741,29 LBP | ( 2,809,741.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Turkey | |
● Package Size: | 1x4ml | |
● Public Price: | 1007.22 TRY | ( 2,699,349.60 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1007,22 TRY | ( 2,698,760.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Spain |
● Package Size: | 1x4ml |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios |
● Pricing Date: | 06/05/2021 |
● Type: | Medicine Authorised |
● Country: | Finland |
● Package Size: | 1x4ml |
● Reference: | Kela |
● Pricing Date: | 22/04/2021 |
● Type: | Medicine Non Marketed |
● Country: | France |
● Package Size: | 1x4ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File